ASTELLAS PHARMA UNSP.ADR (YPHA) — Tangible Net Worth Ratio
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Tangible Net Worth Ratio of 25.7% as of March 2025. This metric is calculated by deducting intangible assets (€1.12 Trillion) from net assets (€1.51 Trillion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ASTELLAS PHARMA UNSP.ADR (YPHA) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ASTELLAS PHARMA UNSP.ADR Tangible Net Worth Ratio (2022–2025)
This chart shows how ASTELLAS PHARMA UNSP.ADR's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 25.7%, reflecting net assets of €1.51 Trillion with intangible assets of €1.12 Trillion EUR. For live market cap and overall valuation, see YPHA market cap.
Annual Tangible Net Worth Ratio for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore YPHA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 25.7% | €1.51 Trillion | €1.12 Trillion | €3.34 Trillion | ▲ +16.8 pp |
| 2024 | 8.9% | €1.60 Trillion | €1.45 Trillion | €3.57 Trillion | ▼ -53.8 pp |
| 2023 | 62.7% | €1.51 Trillion | €562.50 Billion | €2.46 Trillion | ▲ +5.4 pp |
| 2022 | 57.3% | €1.46 Trillion | €623.43 Billion | €2.33 Trillion | — |